Drive strategic initiatives aimed at optimizing the value derived from IT investments across clinical, regulatory, pharmacovigilance and global portfolio: Japan, China etc.Direct the development and implementation of a holistic value evaluation framework for IT projects, overseeing value realization activities. Manage the strategic execution for maximizing investment value and implement a model for managing the value of all investments/products within owned portfolio.Define, own and architect long term technical solution strategies as a thought leader, in collaboration with leadership and across teams. Provide leadership and mentorship to team members, fostering a culture of continuous learning and improvement.

ERODhealth leverages real world data/evidence and our health technology platform expertise to help organizations including academic medical centers, CROs and life science companies on multiple research studies and clinical development to accelerate drug development process, reduce timeline and complexity of research studies. We help our partners in the development of RWD strategies, data qualification, clinical data model design, data partnerships, study concept development, protocol design, implementation of clinical research studies, clinical trial planning, recruitment and secondary analysis of trials. We also provide Pharmacometrics PK/PD predictive modeling of drug doses used in preclinical and all phases of clinical trials or drug development. We also work with medical device start ups/companies and health technology platform on go to market strategy and partnerships. Projects range from outcomes based research studies, HEOR services, diagnostic and treatment aids innovation and go to market strategy. We help our clients leverage real world data in an efficient and effective way thus reducing timeline for research projects and clinical development and significant cost savings. We are building a new platform that reduces the complexity of protocol design by bringing all the pieces together with the help of AI and machine learning which will simplify the protocol design process and shorten timeline for study publication and reduce the overall cost of research studies. Reach out to learn more.

Led RWD/RWE strategies, data and platform evaluation and external partnerships to support a number of our Oncology assets working cross-functionally. Led and supported oncology data mapping with cross functional teams.Represent Takeda Data Science Institute on the CRDSA Secondary Use Standards and External Controls Work streams working with industry leaders and Led the authoring and publishing of manuscript on establishing a basis for secondary use standards for clinical trials: https://www.appliedclinicaltrialsonline.com/view/establishing-a-basis-for-secondary-use-standards-for-clinical-trials#. Led the expansion, transition and operationalization of the Digital Trial Acceleration Initiative from OBU-DD&T into our R&D organization, A cross-functional initiative to build data, digital and analytics capabilities to support the acceleration of Takeda clinical trials piloted in Oncology in both US and EU and expanded as part of an enterprise wide, value creation initiative.

Served as the internal principal investigator, leading the study team from study inception to dissemination of research results. Provide expert guidance around study design, research methodology, analyses and interpretation of results. Performs observational and experimental health economics and outcomes research directed toward the acquisition of new knowledge and to guide business decisions.Prepare comprehensive documents including statement of work and study protocols.Prepare reports, executive summaries and presentations to communicate the research findings and provide insights based on results. Work with government regulators on partnership study protocols and design, analyses and interpretation of results. Publishes research results in peer reviewed publications and present at appropriate scientific conferences and forums.

I worked cross-functionally with partners to leverage COTA’s healthcare data and technology solutions to design and implement go to market strategies that enable the delivery of precision medicine at scale using real-world evidence, powered by the patented COTA Nodal Address System (CNA). The CNA® Platform is the most powerful and easy-to-use solution for analyzing and visualizing real-world, patient-level clinical and cost data.

Developed strategies for the design and implementation of a scale to measure outcomes of alveolar bone grafts in cleft lip and palate patients leveraging RWD (clinical, radiological, surgical and orthodontic data) with clinically relevant and universally applicable end points. Drafted study proposal, protocol, queried clinical data for qualification, and served as the clinician-scientist/expert point of contact for the department on the project and worked with the surgeon in chief on this initiative

• Surgical and palliative management of craniofacial tumors• General dental cases • Fixation of mandibular fractures• Management of pan-facial fractures• Management of odontogenic infections

Surgical management of oral lesions.

Supervision of clinical staff Management of clinical partnerships with industry and community

• Visiting scholar and dental surgeon from December 2010 - March 2011 , May 2012, May-June, 2016 involved in patient care in the outpatient clinic, operating room, and contributing in didactic sessions and hospital rounds